Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Antibiotic Resistance and New Antimicrobial drugs

This article is part of the Research TopicPerspectives in Antibiotic Resistance and New Antimicrobial Drugs: 2025View all 5 articles

Study on the Antibacterial Effect of the New Anti-Biofilm Inhibitor ICAC on Escherichia coli

Provisionally accepted
Yubin  BaiYubin Bai1Zixuan  ShangZixuan Shang1,2Rongbin  HuRongbin Hu1Xun  GaoXun Gao1Zhijin  ZhangZhijin Zhang1,2Bing  LiBing Li1Zhen  ZhuZhen Zhu2*Jiyu  ZhangJiyu Zhang1*
  • 1Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, lanzhou, China
  • 2Hebei University of Engineering, Handan, China

The final, formatted version of the article will be published soon.

The rise of bacteria antibiotics resistance has bacome increasingly severe, and the development of natural compounds with antibacterial activity represents a promising approach to combat this issue. Isochlorogenic acid C (ICAC), a phenolic acid derived from plants, was investigated in this study fou its antibacterial and antibiofilm effects against E. coli, along with the underlying mechanisms. Results revealed that ICAC exhibited significant antibacterial and antibiofilm activity against E. coli. The antibiofilm activity of ICAC against E. coli was assessed using crystal violet (CV) staining, scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM). The results demonstrated that ICAC could inhibit the biofilm formation of Escherichia coli, reduce the biomass of preformed biofilms, and decrease the production of extracellular polysaccharides (EPS) and extracellular proteins, as well as bacterial motility. Moreover, qRT-PCR results showed that ICAC downregulated genes associated with c-di-GMP synthesis while upregulating those involves in c-di-GMP degradation, thereby inhibiting biofilm formation and bacterial motility. In summary, ICAC shows potential as an effective anti-c-di-GMP agent and a novel antibacterial candidate for the treatment of E. coli infections.

Keywords: Stevia rebaudiana isochlorogenic acid C, Escherichia coli, Biofilm, EPS, motility, c-di-GMP

Received: 22 Sep 2025; Accepted: 24 Nov 2025.

Copyright: © 2025 Bai, Shang, Hu, Gao, Zhang, Li, Zhu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Zhen Zhu, zhuzhen234@yeah.net
Jiyu Zhang, zhangjiyu@caas.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.